Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:41 PM
Ignite Modification Date:
2025-12-24 @ 12:41 PM
NCT ID:
NCT05389761
Eligibility Criteria:
Inclusion Criteria:
* Female
* Age between 30 and 59 years (included)
* Diagnosis of fibromyalgia
* Must sign an informed consent
* Able to follow-up at 2 and 6 months
Exclusion Criteria:
* Pregnant or possibly pregnant
* Patients with change of pharmacological treatment in the last 3 months
* Patients with DAO enzyme treatment
* Patients diagnosed with other severe diseases (i.e. cancer, cardiovascular disease, autoimmune disease or metabolic disease)
* Patients with multiple chemical sensitivity
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
30 Years
Maximum Age:
59 Years
Study:
NCT05389761
Study Brief:
Protocol Section:
NCT05389761